BioCentury
ARTICLE | Strategy

Anticoagulant crowd feels squeeze

April 19, 1993 7:00 AM UTC

In this era of cost-consciousness, clinical efficacy may not be enough to convince hospitals and doctors to use new products, particularly in crowded fields such as anticoagulants for acute cardiovascular conditions, where the drugs already on the market are so cheap as to be virtually free.

Many of the factors driving the market sizes for these drugs are pushing in one direction - down - which means that the 13 products in development (see accompanying list) could be competing in smaller markets and at lower prices than the companies originally hoped...